HbA1c as a risk factor for retinopathy and nephropathy in persons with type 1 diabetes

被引：0
|
作者：
Ludvigsson, J. [1 ,2 ]
Pivodic, A. [3 ]
Svensson, A. -M. [4 ]
Olafsdottir, A. F. [5 ]
Wedel, H. [6 ]
Lind, M. [5 ]
机构：
[1] Linkoping Univ, Div Pediat, Linkoping, Sweden
[2] Linkoping Univ, Crown Princess Victoria Childrens Hosp, Linkoping, Sweden
[3] Sahlgrens Acad, Inst Neurosci & Physiol, Stat Konsultgrp, Dept Ophthalmol, Gothenburg, Sweden
[4] Reg Vastra Gotaland, Ctr Registers Rep, Dept Mol & Clin Med, Linkoping, Sweden
[5] Univ Gothenburg, Dept Mol & Clin Med, Gothenburg, Sweden
[6] Univ Gothenburg, Sahlgrenska Acad, Dept Hlth Metr, Gothenburg, Sweden
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1029
引用
收藏
页码：S499 / S500
页数：2
相关论文
共 50 条
  • [21] CLINICAL CORRELATION OF HBA1C AND DIABETIC NEPHROPATHY WITH DIABETIC RETINOPATHY
    Niveditha, H.
    Yogitha, C.
    Liji, P.
    Shetty, Sundeep
    Himamshu, N. V. V.
    Vinutha, B. V.
    Patil, Pooja
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2013, 2 (49): : 9430 - 9435
  • [22] Association of glycated albumin to HbA1c ratio with diabetic retinopathy but not diabetic nephropathy in patients with type 2 diabetes
    Umayahara, Yutaka
    Fujita, Yohei
    Watanabe, Hirotaka
    Kasai, Noriko
    Fujiki, Noritaka
    Hatazaki, Masahiro
    Koga, Masafumi
    CLINICAL BIOCHEMISTRY, 2017, 50 (06) : 270 - 273
  • [23] HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes
    Jiaqi Hu
    Huichun Hsu
    Xiaodan Yuan
    Kezheng Lou
    Cunyi Hsue
    Joshua D. Miller
    Juming Lu
    Yaujiunn Lee
    Qingqing Lou
    Journal of Endocrinological Investigation, 2021, 44 : 1229 - 1236
  • [24] HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes
    Hu, Jiaqi
    Hsu, Huichun
    Yuan, Xiaodan
    Lou, Kezheng
    Hsue, Cunyi
    Miller, Joshua D.
    Lu, Juming
    Lee, Yaujiunn
    Lou, Qingqing
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (06) : 1229 - 1236
  • [25] Impact of HbA1c followed from diagnosis on retinopathy and nephropathy in patients with onset of type 1 diabetes before 35 years
    Arnqvist, H. J.
    Nordwall, M.
    Fredriksson, M.
    Dhir, M.
    Abrahamsson, M.
    Ludvigsson, J.
    DIABETOLOGIA, 2012, 55 : S450 - S451
  • [26] HbA1c control in type 1 diabetes with retinopathy and effects of COVID on national diabetic retinopathy screening programme
    Ng, V.
    Martin, S.
    De Silva, P.
    Akbar, S.
    Takaza, A.
    Mamtora, S.
    Karandikar, S.
    Rweyemamu, J.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 144 - 145
  • [27] HbA1c Predicts Time to Diagnosis of Type 1 Diabetes in Children at Risk
    Helminen, Olli
    Aspholm, Susanna
    Pokka, Tytti
    Hautakangas, Milla-Riikka
    Haatanen, Nora
    Lempainen, Johanna
    Ilonen, Jorma
    Simell, Olli
    Knip, Mikael
    Veijola, Riitta
    DIABETES, 2015, 64 (05) : 1719 - 1727
  • [28] HbA1c and microvascular complications in type 1 diabetes
    Pavlicek, Vojtech
    DIABETOLOGIE, 2023, 19 (01): : 79 - 80
  • [29] HbA1c vs. FPG in Identifying Risk for Diabetes in Older Persons
    Lipska, Kasia J.
    De Rekeneire, Nathalie
    Van Ness, Peter H.
    Johnson, Karen C.
    Kanaya, Alka
    Koster, AnneMarie
    Strotmeyer, Elsa S.
    Goodpaster, Bret H.
    Harris, Tamara
    Gill, Thomas M.
    Inzucchi, Silvio E.
    DIABETES, 2010, 59 : A308 - A309
  • [30] HbA1c variability and the development of nephropathy in individuals with type 1 diabetes mellitus from Rwanda
    Bille, Nathalie
    Byberg, Stine
    Gishoma, Crispin
    Kristensen, Kirza Buch
    Christensen, Dirk Lund
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
12345